A multimethods randomized trial found that plain language versions improved adults understanding of health recommendations.

COVID-19 RCT health information plain language recommendation vaccine recommendations

Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
24 Nov 2023
Historique:
received: 10 08 2023
revised: 17 10 2023
accepted: 17 11 2023
medline: 27 11 2023
pubmed: 27 11 2023
entrez: 26 11 2023
Statut: aheadofprint

Résumé

To make informed decisions, the general population should have access to accessible and understandable health recommendations. To compare understanding, accessibility, usability, satisfaction, intention to implement, and preference of adults provided with a digital "Plain Language Recommendation" (PLR) format versus the original "Standard Language Version" (SLV). An allocation-concealed, blinded, controlled superiority trial and a qualitative study to understand participant preferences. An international on-line survey. 488 adults with some English proficiency. 67.8% of participants identified as female, 62.3% were from the Americas, 70.1% identified as white, 32.2% had a bachelor's degree as their highest completed education, and 42% said they were very comfortable reading health information. In collaboration with patient partners, advisors, and the Cochrane Consumer Network, we developed a plain language format of guideline recommendations (PLRs) to compare their effectiveness versus the original standard language versions (SLVs) as published in the source guideline. We selected two recommendations about COVID-19 vaccine, similar in their content, to compare our versions, one from the World Health Organization (WHO) and one from Centers for Disease Control and Prevention (CDC). The primary outcome was understanding, measured as the proportion of correct responses to seven comprehension questions. Secondary outcomes were accessibility, usability, satisfaction, preference, and intended behavior, measured on a 1-7 scale. Participants randomized to the PLR group had a higher proportion of correct responses to the understanding questions for the WHO recommendation (mean difference [MD] of 19.8%, 95% Confidence Interval [CI] 14.7% to 24.9%; p<0.001) but this difference was smaller and not statistically significant for the CDC recommendation (MD of 3.9%, 95% CI -0.7% to 8.3%; p=0.096). However, regardless of the recommendation, participants found the PLRs more accessible, (MD of 1.2 on the seven-point scale, 95% CI 0.9% to 1.4%; p< 0.001) and more satisfying (MD of 1.2, 95% CI 0.9% to 1.4%; p< 0.001). They were also more likely to follow the recommendation if they had not already followed it (MD of 1.2, 95% CI 0.7% to 1.8 %; p< 0.001) and share it with other people they know (MD of 1.9, 95% CI 0.5% to 1.2 %; p< 0.001). There was no significant difference in the preference between the two formats (MD of -0.3, 95% CI -0.5% to 0.03%; p= 0.078). The qualitative interviews supported and contextualized these findings. And Relevance: Health information provided in a PLR format improved understanding, accessibility, usability, and satisfaction and thereby has the potential to shape public decision-making behavior.

Identifiants

pubmed: 38008266
pii: S0895-4356(23)00303-7
doi: 10.1016/j.jclinepi.2023.11.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Shahab Sayfi (S)

Department of Biology, Faculty of Science, University of Ottawa, Ottawa, ON K1N 6N5, Canada; Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada; Michael G. DeGroote Cochrane Canada and GRADE Centres, Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main St. W., Hamilton, ON L8S 4K1, Canada.

Rana Charide (R)

Michael G. DeGroote Cochrane Canada and GRADE Centres, Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main St. W., Hamilton, ON L8S 4K1, Canada.

Sarah A Elliott (SA)

Alberta Research Center for Health Evidence, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada; Cochrane Child Health, University of Alberta, Edmonton, Alberta, Canada.

Lisa Hartling (L)

Alberta Research Center for Health Evidence, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada; Cochrane Child Health, University of Alberta, Edmonton, Alberta, Canada.

Matthew Munan (M)

Alberta Research Center for Health Evidence, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Lisa Stallwood (L)

Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, M5G 0A4, Canada.

Nancy J Butcher (NJ)

Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, M5G 0A4, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, M5T 1R8, Canada.

Dawn P Richards (DP)

Five02 Labs Inc, Toronto, Ontario, Canada.

Joseph L Mathew (JL)

Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Jozef Suvada (J)

National Evidence and Quality Platform, St. Elizabeth University of Public Health and Social Science, Research Dept., Nam. 1. Maja 1, 81000 Bratislava, Slovak Republic; Experts Consortium for COVID-19, Advisor to government of Slovak Republic; WHO Executive Board, Switzerland.

Elie A Akl (EA)

Michael G. DeGroote Cochrane Canada and GRADE Centres, Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main St. W., Hamilton, ON L8S 4K1, Canada; Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.

Tamara Kredo (T)

Cochrane South Africa, South African Medical Research Council, South Africa; Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences, Stellenbosch University.

Lawrence Mbuagbaw (L)

Michael G. DeGroote Cochrane Canada and GRADE Centres, Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main St. W., Hamilton, ON L8S 4K1, Canada; Department of Anesthesia, McMaster University, Hamilton, ON, Canada; Department of Pediatrics, McMaster University, Hamilton, ON, Canada; Biostatistics Unit, Father Sean O'Sullivan Research Centre, St Joseph's Healthcare, Hamilton, ON, Canada; Centre for Development of Best Practices in Health (CDBPH), Yaoundé Central Hospital, Yaoundé, Cameroon; Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.

Ashley Motilall (A)

Michael G. DeGroote Cochrane Canada and GRADE Centres, Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main St. W., Hamilton, ON L8S 4K1, Canada.

Ami Baba (A)

Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, M5G 0A4, Canada.

Shannon D Scott (SD)

Faculty of Nursing, University of Alberta.

Maicon Falavigna (M)

National Institute for Health Technology Assessment, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.

Miloslav Klugar (M)

Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic; Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.

Tereza Friessová (T)

Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic; Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.

Tamara Lotfi (T)

Michael G. DeGroote Cochrane Canada and GRADE Centres, Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main St. W., Hamilton, ON L8S 4K1, Canada.

Adrienne Stevens (A)

Centre for Immunization Readiness, Public Health Agency of Canada, Ottawa, Ontario, K1A 0K9.

Martin Offringa (M)

Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, M5G 0A4, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, M5T 3M6, Canada; Division of Neonatology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, M5G 1X8, Canada.

Holger J Schünemann (HJ)

Michael G. DeGroote Cochrane Canada and GRADE Centres, Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main St. W., Hamilton, ON L8S 4K1, Canada; Department of Biomedical Sciences, Humanitas University, Milan, Italy. Electronic address: schuneh@mcmaster.ca.

Kevin Pottie (K)

Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada; Department of Family Medicine, Western University, London, Ontario, Canada. Electronic address: kpottie@uwo.ca.

Classifications MeSH